BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ye J, Li R, Yang Y, Dong W, Wang Y, Wang H, Sun T, Li L, Shen Q, Qin C, Xu X, Liao H, Jin Y, Xia X, Liu Y. Comparative colloidal stability, antitumor efficacy, and immunosuppressive effect of commercial paclitaxel nanoformulations. J Nanobiotechnology 2021;19:199. [PMID: 34225762 DOI: 10.1186/s12951-021-00946-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Han Z, Qian Y, Gao X, Yang D, Cai Y, Chen Y, Jin J, Yang Z. Hypoxia-responsive covalent organic framework by single NIR laser-triggered for multimodal synergistic therapy of triple-negative breast cancer. Colloids Surf B Biointerfaces 2023;222:113094. [PMID: 36535221 DOI: 10.1016/j.colsurfb.2022.113094] [Reference Citation Analysis]
2 Ye J, Li R, Cheng J, Liu D, Yang Y, Wang H, Xu X, Li L, Ma P, Liu Y. Comparative Colloidal Stability of Commercial Amphotericin B Nanoformulations Using Dynamic and Static Multiple Light Scattering Techniques. Int J Nanomedicine 2022;17:6047-64. [PMID: 36510621 DOI: 10.2147/IJN.S387681] [Reference Citation Analysis]
3 Zhang W, Xu Y, Shi X, Huang X, Chen R, Xu H, Shi W, Wan X, Wang Y, He J, Li C, Wang J, Zha X. Nanoparticle albumin-bound paclitaxel is superior to liposomal paclitaxel in the neoadjuvant treatment of breast cancer. Nanomedicine (Lond) 2022. [PMID: 35393861 DOI: 10.2217/nnm-2022-0025] [Reference Citation Analysis]
4 Rapozzi V, Moret F, Menilli L, Guerrini A, Tedesco D, Naldi M, Bartolini M, Gani M, Zorzet S, Columbaro M, Milani C, Martini C, Ferroni C, Varchi G. HSA-Binding Prodrugs-Based Nanoparticles Endowed with Chemo and Photo-Toxicity against Breast Cancer. Cancers (Basel) 2022;14:877. [PMID: 35205627 DOI: 10.3390/cancers14040877] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]